Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.09)
# 480
Out of 5,165 analysts
352
Total ratings
43.22%
Success rate
15.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $28.74 | +73.97% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $3.62 | +231.49% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $318.91 | +78.73% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $6.31 | +533.91% | 17 | Aug 4, 2025 | |
| ATAI AtaiBeckley | Maintains: Buy | $10 → $15 | $3.65 | +310.96% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $24.29 | -58.83% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.67 | +199.40% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.36 | +2,673.16% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $7.35 | +920.41% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $30.57 | +227.12% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $15.94 | +339.15% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.00 | +400.00% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $6.30 | +852.38% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $57.37 | +39.45% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $15.11 | +164.73% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.30 | +597.67% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $27.86 | +151.26% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $25.49 | +213.85% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.69 | +491.72% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.46 | +2,092.98% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $9.68 | +1,036.95% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $73.31 | +15.95% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $12.01 | +466.19% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $74.40 | +356.99% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $28.74
Upside: +73.97%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $3.62
Upside: +231.49%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $318.91
Upside: +78.73%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $6.31
Upside: +533.91%
AtaiBeckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $3.65
Upside: +310.96%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $24.29
Upside: -58.83%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.67
Upside: +199.40%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.36
Upside: +2,673.16%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $7.35
Upside: +920.41%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $30.57
Upside: +227.12%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $15.94
Upside: +339.15%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.00
Upside: +400.00%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $6.30
Upside: +852.38%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $57.37
Upside: +39.45%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $15.11
Upside: +164.73%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.30
Upside: +597.67%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $27.86
Upside: +151.26%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $25.49
Upside: +213.85%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.69
Upside: +491.72%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.46
Upside: +2,092.98%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $9.68
Upside: +1,036.95%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $73.31
Upside: +15.95%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $12.01
Upside: +466.19%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $74.40
Upside: +356.99%